New approaches in cancer pharmacology: drug design and development
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | Undetermined |
| Veröffentlicht: |
Berlin u.a.
Springer
|
| Schriftenreihe: | Monographs / European School of Oncology
|
| Schlagworte: |
Internformat
MARC
| LEADER | 00000nam a2200000 ca4500 | ||
|---|---|---|---|
| 001 | BV009905883 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 941121nuuuuuuuugw |||| 00||| und d | ||
| 035 | |a (DE-599)BVBBV009905883 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 044 | |a gw |c DE | ||
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a New approaches in cancer pharmacology |b drug design and development |c P. Workman (ed.) |
| 264 | 1 | |a Berlin u.a. |b Springer | |
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Monographs / European School of Oncology | |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Workman, Paul |e Sonstige |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-012540960 | |
Datensatz im Suchindex
| _version_ | 1823607500377686016 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV009905883 |
| classification_rvk | XI 7000 |
| ctrlnum | (DE-599)BVBBV009905883 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 ca4500</leader><controlfield tag="001">BV009905883</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">941121nuuuuuuuugw |||| 00||| und d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009905883</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New approaches in cancer pharmacology</subfield><subfield code="b">drug design and development</subfield><subfield code="c">P. Workman (ed.)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin u.a.</subfield><subfield code="b">Springer</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Monographs / European School of Oncology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Workman, Paul</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012540960</subfield></datafield></record></collection> |
| id | DE-604.BV009905883 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-09T19:00:35Z |
| institution | BVB |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012540960 |
| open_access_boolean | |
| publishDateSort | 0000 |
| publisher | Springer |
| record_format | marc |
| series2 | Monographs / European School of Oncology |
| spelling | New approaches in cancer pharmacology drug design and development P. Workman (ed.) Berlin u.a. Springer txt rdacontent n rdamedia nc rdacarrier Monographs / European School of Oncology Cytostatikum (DE-588)4068347-3 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Cytostatikum (DE-588)4068347-3 s Workman, Paul Sonstige oth |
| spellingShingle | New approaches in cancer pharmacology drug design and development Cytostatikum (DE-588)4068347-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4076066-2 (DE-588)4073781-0 |
| title | New approaches in cancer pharmacology drug design and development |
| title_auth | New approaches in cancer pharmacology drug design and development |
| title_exact_search | New approaches in cancer pharmacology drug design and development |
| title_full | New approaches in cancer pharmacology drug design and development P. Workman (ed.) |
| title_fullStr | New approaches in cancer pharmacology drug design and development P. Workman (ed.) |
| title_full_unstemmed | New approaches in cancer pharmacology drug design and development P. Workman (ed.) |
| title_short | New approaches in cancer pharmacology |
| title_sort | new approaches in cancer pharmacology drug design and development |
| title_sub | drug design and development |
| topic | Cytostatikum (DE-588)4068347-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Cytostatikum Pharmakotherapie Krebs Medizin |
| work_keys_str_mv | AT workmanpaul newapproachesincancerpharmacologydrugdesignanddevelopment |